BioFlorida, Florida’s leading life sciences association, announced the appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of its Southeast Chapter, effective December 15, 2025. In this role, Dr. Japour will guide efforts to connect and strengthen the life sciences ecosystem across Southeast Florida, helping companies, researchers, investors, and regional partners collaborate and showcase the area’s scientific and innovation strengths.
Health Technology Insights: Allink Biotherapeutics Secures $47Million Series A Extension
BioFlorida’s chapter structure encourages localized engagement, providing opportunities for networking, education, policy advocacy, and regional growth. As Southeast Chapter Chair, Dr. Japour will collaborate closely with BioFlorida leadership and local stakeholders to enhance programming, foster connections, and support continued expansion of the Southeast Florida life sciences community.
Health Technology Insights: Cosette Pharma Launches First Generic CIPRO HC with CGT Exclusivity
Mark Glickman, president and CEO of BioFlorida, noted that Dr. Japour brings extensive experience from biotechnology and large pharmaceutical sectors, along with a deep understanding of scaling innovation. Glickman emphasized that Japour’s expertise will be critical in advancing BioFlorida’s mission and supporting the region’s rapidly growing life sciences footprint.
Dr. Japour expressed his honor at the appointment, highlighting the importance of BioFlorida in promoting innovation across biotechnology, pharmaceuticals, medical devices, diagnostics, health technology, and academic research. He noted that BioFlorida has been instrumental in connecting leaders and raising awareness across the industry. Dr. Japour added that Southeast Florida is home to an expanding network of scientific talent, entrepreneurial energy, and world-class institutions, and he looks forward to accelerating growth, enhancing collaboration, and fostering an environment where life sciences companies can thrive and deliver meaningful impact for patients and healthcare systems globally.
This appointment reinforces BioFlorida’s commitment to providing regional leadership and visibility for Florida’s life sciences industry while supporting innovation, education, and collaboration to drive long-term growth across the state.
Health Technology Insights: Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
